Sana Biotechnology
SANA
SANA
120 hedge funds and large institutions have $507M invested in Sana Biotechnology in 2022 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 41 increasing their positions, 33 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
24% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 17
34% less capital invested
Capital invested by funds: $770M → $507M (-$263M)
70% less call options, than puts
Call options by funds: $8K | Put options by funds: $27K
Holders
120
Holding in Top 10
2
Calls
$8K
Puts
$27K
Top Buyers
| 1 | +$3.26M | |
| 2 | +$2.46M | |
| 3 | +$1.79M | |
| 4 |
Nuveen Asset Management
Chicago,
Illinois
|
+$1.13M |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$1.11M |
Top Sellers
| 1 | -$2.58M | |
| 2 | -$2.48M | |
| 3 | -$2.34M | |
| 4 |
LP
LMR Partners
London,
United Kingdom
|
-$1.8M |
| 5 |
Millennium Management
New York
|
-$1.51M |